Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease - Wikidata - awgldk - TriplyDB

Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease

Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease

http://www.wikidata.org/entity/Q28291979

about

Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants Medical therapies for parenteral nutrition-associated cholestasis in term and preterm infants Alterations in parenteral nutrition management for the treatment of parenteral nutrition-associated cholestasis in term and preterm infants Italian guidelines for the management and treatment of neonatal cholestasis Quantitative Shear-Wave Elastography of the Liver in Preterm Neonates with Intra-Uterine Growth Restriction Innovative parenteral and enteral nutrition therapy for intestinal failure.The use of Omegaven in treating parenteral nutrition-associated liver disease.Chronic parenteral nutrition induces hepatic inflammation, steatosis, and insulin resistance in neonatal pigs.Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation.Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease.Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs Low-Dose Intravenous Soybean Oil Emulsion for Prevention of Cholestasis in Preterm Neonates.Intravenous Lipid Emulsions in Parenteral Nutrition Risk factors for parenteral nutrition–associated liver disease following surgical therapy for necrotizing enterocolitis: A Glaser Pediatric Research Network Study [corrected].A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial.Low-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders.The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).Parenteral Nutrition-Associated Cholestasis in Very Low Birth Weight Infants: A Single Center Experience.Liver disease after intensive care of premature baboons: histopathologic observations.The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants.Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs.GLP-2 delays but does not prevent the onset of necrotizing enterocolitis in preterm pigs.State of the art review: Intravenous fat emulsions: Current applications, safety profile, and clinical implications.Complications associated with parenteral nutrition in the neonate.Implementation, process, and outcomes of nutrition best practices for infants <1500 g.Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates.Risks and benefits of prophylactic cyclic parenteral nutrition in surgical neonates.Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.Phytosterols, Lipid Administration, and Liver Disease During Parenteral Nutrition.Effects of Chromium on Glucose Tolerance in Infants Receiving Parenteral Nutrition Therapy.Potential Hepatotoxicities of Intravenous Fat Emulsions in Infants and Children.Incidence and Risk Factors of Parenteral Nutrition-Associated Cholestasis in Omani Neonates: Single centre experience Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates.Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.Retrospective Dual-Center Study of Parenteral Nutrition-Associated Cholestasis in Premature Neonates: 15 Years' Experience.Use of parenteral fish oil to reverse cholestasis induced by parenteral nutrition in infants with intestinal failure: single-centre case series.A standardized nutrition approach for very low birth weight neonates improves outcomes, reduces cost and is not associated with increased rates of necrotizing enterocolitis, sepsis or mortality.Prevention and treatment of intestinal failure-associated liver disease in children.

P2860

Q24187264-303EBD8A-8CD0-4113-BCDB-4CF50F1FECF9 Q24240289-70C9C0CE-8096-4121-A394-FF0E8F328B90 Q24240633-076D5755-D094-413C-B7C7-E8DC592A6666 Q26782860-404FF925-DD5C-4471-A0D1-40A5E8BC0A8F Q30397979-580A8F54-D257-424B-B33E-806BF1128BC0 Q33641177-AC5909F5-FC63-4689-A356-6F93F2473851 Q34174212-E1D109D9-893B-4FAC-87D3-5F829B08C621 Q34308287-5D2C270E-17DE-41DF-A2EE-A9B03AA2773F Q34624462-A3D37DBD-C930-473A-A5B2-C37E70220DE2 Q34769049-C29B7229-B849-47AE-AC8C-F48BCB6FFB5F Q35679248-E820BA33-63A5-4650-B147-7267C081B4C2 Q35858834-CD46E2E6-D3A7-4461-9793-2D40476BF18A Q35956445-9C2292DA-759E-48A2-B0B3-3B0B05588226 Q36033721-B0CC361F-7051-4C4F-9D4F-1AE2127CBCBA Q36239681-77405D26-1C81-445E-8C49-F4B1BEE1C770 Q36254936-34261D88-8640-494D-AE13-E4AEA3FAD8C0 Q36328532-66425D4E-1AFA-4B34-85D2-D8BA8AA03192 Q36538113-0303FC40-B0B0-4AF1-AD7A-9DE464DC71DA Q36768629-8CC4A92D-D9BC-4DE1-BD43-AD1B2B6CF5C0 Q37082445-826D2B1E-7EAF-45F0-A6A5-A849E0E5FEF5 Q37274324-E5A08A21-5B23-4080-A326-E1B7FED66FED Q37538088-BC1A084C-38CD-401B-BDAD-91BDCDCD03A4 Q37603224-62F369DC-812B-4F98-8793-631B4479918A Q37685841-3E09291B-76F3-489C-84CE-367AD3427FC9 Q37717898-F396D747-1999-48F9-A330-A6908219B897 Q37742150-232701C1-757C-4F4D-8CB0-592E8770D1E7 Q37938808-D11B6F34-4C48-4FA6-A3DD-D4C198321B03 Q38024333-8D52B82B-05C4-46E4-A3FE-8C6A6E3843E7 Q38150924-C20036B3-C655-4930-8B40-3FE843009A31 Q38178585-333EE04C-5723-4EA4-B927-3C2AF25E5305 Q38547689-FA18F22D-191F-4CE6-882D-5657933A334A Q38751122-13A1C4F9-6DBA-4234-92EA-87EAD3B7664D Q38931529-773115D1-E7B1-471E-9811-AF79BAD9CFCA Q38998254-53057E4E-6D3A-4B6C-AC50-4DF185F4528F Q39106629-309C44CC-8D6B-4E4E-B8C1-9D49508CA72B Q39502863-635763A7-5B8C-44B9-9957-55B56E598644 Q40353357-2032FF7D-BDB6-43BF-BE1F-007A36A2A4F0 Q41262822-B34978CD-2243-4C16-99B6-6A68F40488C1 Q41931918-010BEF45-970B-4B9B-946F-E00307DB95E2 Q42765644-EAB6DD0C-4A16-497A-A42A-8D197365150F

P2860

Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease

http://www.wikidata.org/entity/Q28291979

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

Identifying patients, on the f ...... ition-associated liver disease

@ast

Identifying patients, on the f ...... ition-associated liver disease

@en

Identifying patients, on the f ...... ition-associated liver disease

@nl

type

label

Identifying patients, on the f ...... ition-associated liver disease

@ast

Identifying patients, on the f ...... ition-associated liver disease

@en

Identifying patients, on the f ...... ition-associated liver disease

@nl

prefLabel

Identifying patients, on the f ...... ition-associated liver disease

@ast

Identifying patients, on the f ...... ition-associated liver disease

@en

Identifying patients, on the f ...... ition-associated liver disease

@nl

P1433

Q28291979-B74B438D-D194-43C1-9E7F-600DDE8FB109

P1476

Q28291979-B30F8EAB-A5ED-4129-AF71-B1863C020CE2

P2093

Q28291979-1CAB937D-4FA5-42A6-AA07-22BDB8B4B1B1

Q28291979-224425A7-B579-4899-AC25-980450DC362E

Q28291979-6CD3B0C4-6327-4232-88F8-6F8A89CE01B2

Q28291979-9FCD1FDF-3A48-408E-96E5-4A7846AAAB6C

Q28291979-BAFC01CF-CB5A-483C-99C2-7315C690C056

P2860

Q28291979-08EB83AE-D4B5-4920-B056-1DF492712454

Q28291979-0A6A17F9-52CD-445F-B198-AFB8ABBA08B5

Q28291979-2BE51647-24AF-479B-8739-0D3829EB7D10

Q28291979-70D7565D-B663-4BFA-BA00-2E061D58383C

Q28291979-85E02E0E-F7D5-4DCC-A913-94776B3D707C

Q28291979-BCED68AD-9F89-4155-B10C-3AEB541E0205

Q28291979-C23CE891-5EE0-4746-A669-913B4E7CD460

Q28291979-CC532600-E721-4FBB-8431-977C287E7BDB

Q28291979-CC782D62-AB54-4FBA-ACB6-E10EF1611573

Q28291979-CE110A6E-663E-47BB-A49E-B6A0BEBDCA41

P2888

Q28291979-01CF8D34-7D6A-49EE-9F2F-7689C4EBD8F5

P304

Q28291979-C076C5F1-9567-4F38-8393-E0EEC304BD8F

P31

Q28291979-79130013-5920-4028-B4F5-74214A87AEB0

P3181

Q28291979-9C873CCF-D9EC-4E97-B51D-CB2DC99B7D52

P356

Q28291979-0EE1F253-1D65-4530-B496-3F9B8FC5A6BA

P407

Q28291979-7D8DB021-B89B-4629-A05A-416F42DEFC61

P433

Q28291979-0908DAF5-70DB-4375-89F2-4C25C338E473

P478

Q28291979-75E945BF-E5C7-496A-8A69-72363B8B777E

P577

Q28291979-61EFAE05-D8AE-4EDB-8D53-456D3C678FCB

P5875

Q28291979-D80B9BA7-EEFA-4147-89B5-9136AEA5E644

P6179

Q28291979-0460F52F-6C35-496B-A00A-8279BC04B239

P698

Q28291979-A7143E2F-1703-416A-B182-276E6690C530

P921

Q28291979-3ED21C3C-EEB2-4257-8814-C0C279E0A3F2

P3181

P356

P1433

Journal of Perinatology

P1476

Identifying patients, on the f ...... ition-associated liver disease

@en

P2093

D K Lambert

http://www.w3.org/2001/XMLSchema#string

E Henry

http://www.w3.org/2001/XMLSchema#string

J Burnett

http://www.w3.org/2001/XMLSchema#string

R D Christensen

http://www.w3.org/2001/XMLSchema#string

S E Wiedmeier

http://www.w3.org/2001/XMLSchema#string

P2860

Association of lipid peroxidation with hepatocellular injury in preterm infants

Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management

Early aggressive nutrition in preterm infants.

Aggressive nutrition of the very low birthweight infant.

Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases.

Intestinal failure-associated liver disease: what do we know today?

Phenobarbital does not prevent total parenteral nutrition-associated cholestasis in noninfected neonates.

Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease.

Neonatal short bowel syndrome: a cohort study.

Hepatic copper in patients receiving long-term total parenteral nutrition.

P2888

P304

284-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5098002

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.JP.7211686

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6461798

http://www.w3.org/2001/XMLSchema#string

P6179

1043762956

http://www.w3.org/2001/XMLSchema#string

P698

17344923

http://www.w3.org/2001/XMLSchema#string

P921